Igovomab

WikiDoc Resources for Igovomab
Articles
Most recent articles on Igovomab Most cited articles on Igovomab Review articles on Igovomab Articles on Igovomab in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Igovomab Images of Igovomab Photos of Igovomab Podcasts & MP3s on Igovomab Videos on Igovomab
Evidence Based Medicine
Cochrane Collaboration on Igovomab Bandolier on Igovomab TRIP on Igovomab
Clinical Trials
Ongoing Trials on Igovomab at Clinical Trials.gov Trial results on Igovomab Clinical Trials on Igovomab at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Igovomab NICE Guidance on Igovomab NHS PRODIGY Guidance FDA on Igovomab CDC on Igovomab
Books
Books on Igovomab
News
Igovomab in the news Be alerted to news on Igovomab News trends on Igovomab
Commentary
Blogs on Igovomab
Definitions
Definitions of Igovomab
Patient Resources / Community
Patient resources on Igovomab Discussion groups on Igovomab Patient Handouts on Igovomab Directions to Hospitals Treating Igovomab Risk calculators and risk factors for Igovomab
Healthcare Provider Resources
Symptoms of Igovomab Causes & Risk Factors for Igovomab Diagnostic studies for Igovomab Treatment of Igovomab
Continuing Medical Education (CME)
CME Programs on Igovomab
International
Igovomab en Espanol Igovomab en Francais
Business
Igovomab in the Marketplace Patents on Igovomab
Experimental / Informatics
List of terms related to Igovomab

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Igovomab is a mouse monoclonal antibody and which it is used to treat ovarian cancer.